文献速递治疗药物监测与药物基因组学特殊人群用药

妥布霉素暴露监测:临床实践中最佳估算方法与采血时间

Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?
PubMed 文献 · Clin Pharmacokinet · 2019-01-01

该研究在12例成人囊性纤维化患者中,比较了21种采血时间组合下对数线性回归与贝叶斯预测法对妥布霉素AUC0-24的估算偏差及剂量调整差异。结果显示采血时间显著影响AUC估算偏差,贝叶斯预测法可减少采样时间对剂量决策的影响。

要点

  • 采血时间显著影响妥布霉素AUC0-24估算偏差,进而导致剂量调整差异。
  • 贝叶斯预测法较对数线性回归法偏差更小,且受采血时间影响更小。
  • 对数线性回归法最无偏估算采血时间为输注开始后100/640分钟,贝叶斯法为70/160分钟。

核心结论

  • 采血时间显著影响AUC0-24估算偏差,导致剂量调整差异很大;使用贝叶斯预测法可减少采血时间对剂量决策的影响。

研究设计与样本

  • 成人囊性纤维化患者接受每日一次静脉妥布霉素,在一个24小时给药间期内密集采血确定真实暴露(AUC0-24),并对21种采血时间组合分别用对数线性回归和贝叶斯预测法估算AUC0-24,与真实值比较相对预测误差并计算后续剂量推荐差异。

主要发现

  • 21种采血组合中,对数线性回归法的中位相对预测误差范围为-34.7%至45.5%,贝叶斯预测法为-14.46%至11.23%。
  • 对数线性回归法最无偏的暴露估算采血时间为输注开始后100/640分钟,贝叶斯预测法为70/160分钟。
  • 后续剂量推荐因估算方法和采血时间不同而差异很大。

临床怎么用

  • 临床采用贝叶斯预测法进行妥布霉素治疗药物监测可减少采血时间对剂量决策的影响。
  • 若使用对数线性回归法,应考虑在输注开始后100/640分钟采血以减小AUC估算偏差。

局限性

  • 研究样本量较小(12例成人囊性纤维化患者),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this article is to investigate the influence of blood sampling times on tobramycin exposure estimation and clinical decisions and to determine the best sampling times for two estimation methods used for therapeutic drug monitoring. METHODS: Adult patients with cystic fibrosis, treated with once-daily intravenous tobramycin, were intensively sampled over one 24-h dosing interval to determine true exposure (AUC0-24). The AUC0-24s were then estimated using both log-linear regression and Bayesian forecasting methods for 21 different sampling time combinations. These were compared to true exposure using relative prediction errors. The differences in subsequent dose recommendations were calculated. RESULTS: Twelve patients, with a median (range) age of 25 years (18-36) and weight of 66.5 kg (50.6-76.4) contributed 96 tobramycin concentrations. Five hundred and eighty-eight estimated AUC0-24s were compared to 12 measured true AUC0-24 values. Median relative prediction errors ranged from - 34.7 to 45.5% for the log-linear regression method and from - 14.46 to 11.23% for the Bayesian forecasting method across the 21 sampling combinations. The most unbiased exposure estimation was provided from concentrations sampled at 100/640 min after the start of the infusion using log-linear regression and at 70/160 min using Bayesian forecasting. Subsequent dosing recommendations varied greatly depending on the estimation method and the sampling times used. CONCLUSION: Sampling times markedly influence bias in AUC0-24 estimation, leading to greatly varied dose adjustments. The impact of blood sampling times on dosing decisions is reduced when using Bayesian forecasting.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Gao Y, Hennig S, Barras M, et al. Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice? Clin Pharmacokinet. 2019. PMID: 30140975. doi:10.1007/s40262-018-0707-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。